These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 8003791)
1. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of molluscum contagiosum in males. A placebo-controlled, double-blind study. Syed TA; Lundin S; Ahmad M Dermatology; 1994; 189(1):65-8. PubMed ID: 8003791 [TBL] [Abstract][Full Text] [Related]
2. Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream: a placebo-controlled, double-blind study. Syed TA; Goswami J; Ahmadpour OA; Ahmad SA J Dermatol; 1998 May; 25(5):309-13. PubMed ID: 9640884 [TBL] [Abstract][Full Text] [Related]
3. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of condylomata acuminata in women. A placebo-controlled, double-blind study. Syed TA; Lundin S; Ahmad SA Dermatology; 1994; 189(2):142-5. PubMed ID: 8075441 [TBL] [Abstract][Full Text] [Related]
4. Human leukocyte interferon-alpha versus podophyllotoxin in cream for the treatment of genital warts in males. A placebo-controlled, double-blind, comparative study. Syed TA; Cheema KM; Khayyami M; Ahmad SA; Ahmad SH; Ahmad S; Ahmad SA Dermatology; 1995; 191(2):129-32. PubMed ID: 8520059 [TBL] [Abstract][Full Text] [Related]
5. Topical treatment of penile condylomata acuminata with podophyllotoxin 0.3% solution, 0.3% cream and 0.15% cream. A comparative open study. Syed TA; Lundin S Dermatology; 1993; 187(1):30-3. PubMed ID: 8324274 [TBL] [Abstract][Full Text] [Related]
6. Human leukocyte interferon-alpha in cream for the treatment of genital herpes in Asian males. A placebo-controlled, double-blind study. Syed TA; Cheema KM; Kahlon BM; Kahlon RC; Khayyami M; Kahlon AM; Kahlon MM Dermatology; 1995; 191(1):32-5. PubMed ID: 8589479 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of topical application of 15% and 10% potassium hydroxide for the treatment of Molluscum contagiosum. Teixidó C; Díez O; Marsal JR; Giner-Soriano M; Pera H; Martinez M; Galindo-Ortego G; Schoenenberger JA; Real J; Cruz I; Morros R Pediatr Dermatol; 2018 May; 35(3):336-342. PubMed ID: 29479727 [TBL] [Abstract][Full Text] [Related]
8. Self-treatment using a 0.5% podophyllotoxin cream of external genital condylomata acuminata in women. A placebo-controlled, double-blind study. von Krogh G; Hellberg D Sex Transm Dis; 1992; 19(3):170-4. PubMed ID: 1523534 [TBL] [Abstract][Full Text] [Related]
9. The successful treatment of molluscum contagiosum with podophyllotoxin (0.5%) self-application. Markos AR Int J STD AIDS; 2001 Dec; 12(12):833. PubMed ID: 11791521 [No Abstract] [Full Text] [Related]
10. An open label safety study of topical imiquimod 5% cream in the treatment of Molluscum contagiosum in children. Barba AR; Kapoor S; Berman B Dermatol Online J; 2001 Feb; 7(1):20. PubMed ID: 11328641 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Topical Cantharidin Treatment for Molluscum Contagiosum and Warts: A Systematic Review. Vakharia PP; Chopra R; Silverberg NB; Silverberg JI Am J Clin Dermatol; 2018 Dec; 19(6):791-803. PubMed ID: 30097988 [TBL] [Abstract][Full Text] [Related]
12. Management of genital warts in women with human leukocyte interferon-alpha vs. podophyllotoxin in cream: a placebo-controlled, double-blind, comparative study. Syed TA; Khayyami M; Kriz D; Svanberg K; Kahlon RC; Ahmad SA; Ahmad SA J Mol Med (Berl); 1995 May; 73(5):255-8. PubMed ID: 7670929 [TBL] [Abstract][Full Text] [Related]
13. Topical treatment of genital warts in men, an open study of podophyllotoxin cream compared with solution. Strand A; Brinkeborn RM; Siboulet A Genitourin Med; 1995 Dec; 71(6):387-90. PubMed ID: 8566979 [TBL] [Abstract][Full Text] [Related]
14. Double-blind, randomized, placebo-controlled trial of the use of topical 10% potassium hydroxide solution in the treatment of molluscum contagiosum. Short KA; Fuller LC; Higgins EM Pediatr Dermatol; 2006; 23(3):279-81. PubMed ID: 16780480 [TBL] [Abstract][Full Text] [Related]
15. Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum. Eichenfield LF; Siegfried E; Kwong P; McBride M; Rieger J; Glover D; Willson C; Davidson M; Burnett P; Olivadoti M Am J Clin Dermatol; 2021 Mar; 22(2):257-265. PubMed ID: 33599960 [TBL] [Abstract][Full Text] [Related]
16. Berdazimer gel for molluscum contagiosum in patients with atopic dermatitis. Paller AS; Green LJ; Silverberg N; Stripling S; Cartwright M; Enloe C; Wells N; Kowalewski EK; Maeda-Chubachi T Pediatr Dermatol; 2024; 41(3):438-444. PubMed ID: 38413239 [TBL] [Abstract][Full Text] [Related]
17. Randomized placebo-controlled clinical trial on efficacy and safety of topical 10% Potassium hydroxide for Giner-Soriano M; Teixidó C; Marsal JR; Díez O; Pera H; Vlacho B; Morros R; J Dermatolog Treat; 2019 Dec; 30(8):750-756. PubMed ID: 30668179 [No Abstract] [Full Text] [Related]
18. Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical Trials. Eichenfield LF; McFalda W; Brabec B; Siegfried E; Kwong P; McBride M; Rieger J; Willson C; Davidson M; Burnett P JAMA Dermatol; 2020 Dec; 156(12):1315-1323. PubMed ID: 32965495 [TBL] [Abstract][Full Text] [Related]
19. Imiquimod therapy for molluscum contagiosum. Liota E; Smith KJ; Buckley R; Menon P; Skelton H J Cutan Med Surg; 2000 Apr; 4(2):76-82. PubMed ID: 11179929 [TBL] [Abstract][Full Text] [Related]
20. An open, nonrandomized, comparative study of imiquimod 5% cream versus 10% potassium hydroxide solution in the treatment of molluscum contagiosum. Metkar A; Pande S; Khopkar U Indian J Dermatol Venereol Leprol; 2008; 74(6):614-8. PubMed ID: 19171985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]